Speaker Details

Rhoda Myra Alani, MD, FAAD

Rhoda Myra Alani, MD, FAAD

Brigham and Women's Hospital/Harvard Medical School

BIOGRAPHY

Dr. Rhoda M. Alani is a nationally recognized leader in academic dermatology who served as the Herbert Mescon Endowed Professor and Chair of Dermatology at Boston University School of Medicine and the Dermatologist-in-Chief at Boston Medical Center from January 2010 until Spring 2024 and currently serves as Visiting Professor of Medicine at Harvard Medical School, Professor of Dermatology at Georgetown University School of Medicine and Adjunct Professor in Oncology at Johns Hopkins University School of Medicine. Dr. Alani received her M.D. degree with honors and distinction in research from the University of Michigan. She went on to an internship in internal medicine at Yale-New Haven Hospital and a residency in dermatology at Harvard Medical School. Following her clinical training, Dr. Alani was a research fellow at the Harvard Cancer Center where her work was highly regarded and led to the receipt of a prestigious research training award from the National Institutes of Health. Dr. Alani further developed her research interests as a research fellow at Memorial Sloan-Kettering Cancer Center. She moved to Johns Hopkins in 1999 as an Assistant Professor of Oncology (primary), with secondary appointments in Dermatology, and Molecular Biology and Genetics; was promoted to Associate Professor in 2004 and became an Adjunct Professor of Oncology upon her move to Boston University. She is the recipient of numerous awards and honors including membership in Phi Beta Kappa and Alpha Omega Alpha Honor Societies, The American Society for Clinical Investigation, The Association of Professors of Dermatology, The American Dermatological Association, The American Academy of Dermatology, The Society for Investigative Dermatology, The Women’s Dermatologic Society, The Society for Melanoma Research, The American Association for Cancer Research, The New England Dermatological Society, and The Massachusetts Academy of Dermatology. Dr. Alani is a highly cited scientist with over 100 publications and presentations, and is a co-editor of the recent textbook, Melanoma in Clinical Practice (Springer, 2021). She has also served on the editorial boards of the Journal of Investigative Dermatology and Pigment Cell and Melanoma Research as well as a reviewer for dozens of prestigious scientific journals including Cell, Science, Nature and the New England Journal of Medicine. Dr. Alani is a co-founder of Acylin Therapeutics, a biotechnology venture focused on the development of epigenetic therapeutics. Her work has been received with great acclaim by both the scientific and lay community and has been highlighted in The Lancet, ABC News, Fox News, Glamour Magazine, the Boston Globe, and The Baltimore Sun.

SESSIONS

U047 Blood Testing for Skin Cancers: Updates on the Use of Liquid Biopsies in Cutaneous Oncology
Mar 21, 2027 • 8:00 AM - 9:00 AM

DISCLOSURES

No financial relationships exist with ineligible companies.